Accession Number: | 0001209191-20-007481 |
Date: | 2020-02-05 |
Issuer: | VERTEX PHARMACEUTICALS INC / MA (VRTX) |
Original Submission Date: |
BOZIC CARMEN
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-02-05 | A | 2,098 | a | $0.00 | 4,195 | direct | ||
COMMON STOCK | 2020-02-05 | A | 10,323 | a | $0.00 | 14,518 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | represents earned performance shares with respect to a performance stock unit award granted on 05/20/2019 that contained performance-vesting requirements. the issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. the earned performance shares will vest in installments beginning on 2/24/2020. |
f2 | restricted stock unit award that vests in installments beginning on 02/10/2021. |